CLINICAL_TRIALS
trial_result
· 2021-04-27
Clinical Trial Update: ABSORICA in Patients With Severe Recalcitrant Nodular Acne [Phase 4]
Summary
Phase 4 trial update for ABSORICA in patients with severe recalcitrant nodular acne has completed and results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sun Pharmaceutical Industries Limited | Conditions: Acne | Phase 4 | Status: COMPLETED | Results posted: 2021-04-27